The largest database of trusted experimental protocols

Scopolamine

Scopolamine is a tropane alkaloid compound derived from plants of the Solanaceae family, including Hyoscyamus, Atropa, and Datura species.
It is a potent muscarinic acetylcholine receptor antagonist with diverse pharmacological effects, including anitsecretory, antispasmodic, and sedative properties.
Scopolamine has been used clinically as an antimotion sicknes agent, a preoperative sedative, and a treatment for postoperative nausea and vomiting.
Reserchers utilize scopolamine in a variety of experimental and clinical settings to study its effects on the central nevous system, cognition, and other physiological processes.
This MeSH term provides a concise overview of the key pharmacological properties and therapeutic applications of scopolamine.

Most cited protocols related to «Scopolamine»

Spontaneous alternation tests were conducted in the same Y-maze as described above. For this test, the Y-maze was rotated by 45° and the distal cues differed between the forced and the spontaneous alternation test. This test consisted of a single 5 min trial, in which the mouse was allowed to explore all three arms of the Y-maze. If a mouse climbed on the maze walls, it was immediately returned to the abandoned arm. The start arm was varied between animals to avoid placement bias. For the scopolamine experiment, mice were dosed with scopolamine or vehicle 30–40 min before the experiment. Spontaneous Alternation [%] was defined as consecutive entries in 3 different arms (ABC), divided by the number of possible alternations (total arm entries minus 2; [30 (link)]). Re-entries into the same arm were rated as separate entries, which resulted in a 22.2% chance level for continuous alternation [31 (link)]. Mice with less than 8 arm entries during the 5-min trial were excluded from the analysis [18 (link)].
Full text: Click here
Publication 2016
Animals MAZE protocol Mice, House Scopolamine
A detailed description of the methods used can be found in the online supplementary materials.
Male Wistar-Han rats (n = 20) were implanted with cannulae and electrodes, and a second set of rats (n = 16) were implanted with cannulae. Experimental protocols conformed to NIH guidelines, and were approved by INSERM and by the IACUC of the University of California-Irvine. Continuous video/EEG monitoring was performed.
To induce status epilepticus (SE), kainic acid (KA) was given by intraperitoneal injection once per hour (5 mg/kg), and pilocarpine hydrochloride (310 mg / kg) was injected 30 minutes after a preliminary scopolamine injection (1mg/kg).
To assess molecular changes and in vitro physiology, rats were infused with ordered or scrambled oligonucleotides (ODNs) on days 1 (10 nmol), and 2 (5nmol) after the SE. Electrophysiological and biochemical studies were performed on the day following the 2nd infusion. For long-term effects of the ODN in vivo, repeated infusions alternated full dose (10 nmol/hemisphere) and half dose the following post-SE days: day 1 (full dose), day 2 (half dose), day 3 (half dose), day 6 (full dose), day 8 (half dose), day 10 (full dose). Recordings were discontinued on day 13 post-SE.
Analysis of seizures, interictal activities and theta rhythm were performed as described previously 25 (link).
Organotypic hippocampal slice cultures were prepared as described before26 (link),27 (link) using P8 rats. Phosphorothioate oligodeoxynucleotides, were added in the culture medium (1 μM) 3 hours after treatment with kainic acid that provoked seizure-like events28 (link). Cultures were assessed for HCN expression 2-days after KA, and for NRSF at 4h-7d.
Animals used for NRSF, HCN1, HCN2 and Kv4.2 measurements were decapitated and the hippocampi were rapidly dissected. Organotypic slice culture tissues were harvested directly from the membranes. All tissues were processed for Western Blot analyses as described in the supplementary methods.
Chromatin immunoprecipitation was performed, as described in the supplementary methods, to detect the physical binding of transcription factors and histones to DNA.
Hippocampal slices were prepared from the dorsal hippocampus and recordings performed as previously described 10 (link).
SPSS software was used for statistical analysis. We used non parametric Mann-Whitney test for samples lower than 6 in size, and t-test otherwise. Results are expressed as mean ± s.e.m, with p<0.05 considered significant.
Publication 2011
Aftercare Animals Culture Media Histones Immunoprecipitation, Chromatin Injections, Intraperitoneal Institutional Animal Care and Use Committees Kainic Acid Longterm Effects Males Microphysiological Systems Oligodeoxyribonucleotides Oligonucleotides Physical Examination physiology Pilocarpine Hydrochloride Rats, Wistar Rattus norvegicus Scopolamine Seahorses Seizures Status Epilepticus Theta Rhythm Tissue, Membrane Tissues Transcription Factor Western Blot

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Aluminum Cognition MAZE protocol Mice, House Scopolamine
We recorded extracellular neuronal activity from three hemispheres in three male macaque monkeys (Macaca mulatta), whilst applying ACh, scopolamine or mecamylamine iontophoretically on selected trials. Animals were implanted with a custom made head-holding device and recording chambers made of Tecapeek GF for compatibility in functional magnetic resonance imaging settings. Surgical procedures were performed under aseptic conditions and general anaesthesia. Experiments and surgeries were performed in accordance with the European Communities Council Directive 1986 (86/609/EEC), the National Institutes of Health (Guidelines for Care and Use of Animals for Experimental Procedures), the Society for Neurosciences Policies on the Use of Animals and Humans in Neuroscience Research, and the UK Animals Scientific Procedures Act.
The monkey’s task was to detect a small change in luminance at a cued (attended) location, while ignoring a change that occurred at a non-cued location and fixating a central fixation spot throughout the trial. After a fixation-only period, two identical stimuli were presented (test stimuli): one centred on the receptive field and the other at the same eccentricity in the opposite hemi-field. After 500–800 ms (randomized in 1 ms steps) a patch appeared at the centre of one of the bars. If presented in the cued location the monkey had to release the touch bar within 500 ms to receive a juice reward. If presented in the un-cued location the monkey had to continue to hold the touch bar and maintain fixation until target appearance. This occurred 1,000–1,300 ms (randomized in 1 ms steps) after the distracter appeared. Thus, we recorded activity when animals attended to the receptive field of the neuron under study and when they attended away from it. We then compared activity levels for these attentional conditions with and without drug application.
For all further information about the paradigm, the neuronal recordings, iontophoresis and data analysis, see Supplementary Methods.
Publication 2008
Animals Asepsis Attention General Anesthesia Head Homo sapiens Iontophoresis Macaca Macaca mulatta Males Mecamylamine Medical Devices Monkeys Neurons Operative Surgical Procedures Pharmaceutical Preparations Scopolamine Touch
Forced alternation tests were conducted using a symmetrical Y-maze made of a grey steel bottom plate with grey Perspex® walls (Stoelting Co, Wood Dale, IL). Each arm of the Y-maze was 35 cm long, 5 cm wide, and 10 cm high, and the wall at the end of each arm was marked with a different black and white pattern. To reduce anxiety in the animals, light in the testing area was dimmed to 30 ± 5 lux.
The protocol for the forced alternation test was modified from Melnikova et al. [21 (link)]. Mice were handled for three days before testing. The test consisted of a 5 min sample trial (T1) followed by a 5 min retrieval trial (T2). For the scopolamine experiment, mice were dosed with scopolamine or vehicle 30 min before T1. In T1, the mouse was placed into the end of the start arm, facing the wall and away from the center. The mouse was then allowed to explore two arms of the Y-maze, while entry into the third arm was blocked. After the sample trial, the mouse was returned to its home cage for a 30 min inter-trial interval. In T2, the block in arm 3 was removed, the mouse was again placed into the start arm, and then allowed to access all three arms of the maze. If a mouse climbed on the maze wall, it was immediately returned into the abandoned maze arm. After each animal and between T1 and T2, the maze was wiped with a Quatricide® dilution to prevent odor cues. An arm entry was recorded when 85% of a mouse’s body entered the arm. Time in Novel Arm [%] was defined as the time spent in the novel arm divided by the time spent in all arms during the first minute of the retrieval trial T2. Forced Alternation [%] was defined as the percent of mice entering first the novel arm during T2 [22 (link)]. Mice with less than three arm entries in the first minute of T2 were excluded from the analysis.
Full text: Click here
Publication 2016
Animals Anxiety Human Body Light MAZE protocol Mice, House Odors Perspex Scopolamine Steel Technique, Dilution

Most recents protocols related to «Scopolamine»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Acetaminophen Anesthesia Anesthesia, Conduction Anesthesiologist Antibiotics, Antitubercular Aprepitant Aspirin Bupivacaine Cefazolin Cephalexin Chemoprevention Chlorhexidine chlorhexidine gluconate Clindamycin Deep Vein Thrombosis Dexamethasone Ethanol Famotidine Fentanyl Gabapentin Hypersensitivity Ibuprofen Isopropyl Alcohol Management, Pain Medical Devices Meloxicam Nerve Block Ondansetron Operative Surgical Procedures Oxycodone Pain, Postoperative Patients Penicillins Percocet Postoperative Nausea Powder Ropivacaine Scopolamine Skin Surgery, Day Therapeutics Thigh Treatment Protocols Ultrasonics Vancomycin Wounds
The administration of scopolamine, an antagonist of muscarinic acetylcholine receptors, causes a temporary blockade of receptors, impaired cognitive functions and cerebral metabolism, which is considered to be a reliable model of AD (Buccafusco, 2009 ). Scopolamine aqueous solution was prepared by dissolving weighed sample in water for injection. A solution of scopolamine was injected intraperitoneally at a dose of 1.5 mg/kg/5 mL once 30 min before testing of the passive avoidancereflex (only on the first day - the day of training).
Full text: Click here
Publication 2023
Cholinergic Receptors Cognition Metabolism Muscarinic Antagonists Scopolamine
The administration of scopolamine, an antagonist of muscarinic acetylcholine receptors, causes a temporary blockade of these receptors that impaired cognitive functions (Buccafusco, 2009 ).
For 8 days, animals received oraly latrepirdine polymorphs according to group affiliation (Table 3). Polymorph preparations of latrepirdine at a dose of 10 mg/kg were administered to experimental animal groups (groups 3–8) once a day for 7 days. The groups 1 and 2 were administered once a day with an equivalent amount of corn oil.
To study cognitive-enhancing nootropic effect of the polymorphs the passive avoidance (PA) test was performed as described by Burwell et al. (Burwell et al., 2004 (link)). The PA apparatus (Neurobotics, Moscow, Russia) consisting of two compartments (light and dark chambers) separated by sliding guillotine door was used. PA consisted of an acquisition trial on the first (training) day and a retention trial 24 h later. On the seventh day of corn oil or the test polymorph administration, the animals were placed for 5 min in the PA unit to familiarize themselves with the space in order to avoid the stress caused by the new environment. The next day (eighth day) the training phase of PA test was started. 60 min before the start of training, corn oil or the test polymorph was administered, as per the group design. The experimental groups (2–8) were injected intraperitoneally with scopolamine at a dose of 1.5 mg/kg 30 min before training. During the training phase of PA test each rat was placed in the lighted chamber. After 10 s, the door was opened, and latency to enter the dark chamber was recorded. An animal was considered to have entered the dark chamber when all fours paws were beyond the guillotine door. After entry, the door was closed. After 2 s had elapsed, a foot shock stimulus was delivered. The shock level and duration were set at 1 mA for 2 s. The rat was immediately removed back to its home cage. Twenty-4 hours later (ninth day), a retention test consisted of placing the rat back into the lighted chamber, waiting 10 s, opening the door, and the latent period (LP) of the first entry into the dark chamber was recorded. If a rat did not enter the chamber in 180 s, the trial was terminated, and the rat was removed to the home cage.
The most effective polymorph was determined.
Full text: Click here
Publication 2023
Animals Animals, Laboratory Cholinergic Receptors Cognition Corn oil Foot latrepirdine Muscarinic Antagonists Neutrophil Nootropic Agents Retention (Psychology) Scopolamine Shock
Statistical processing of the results of a comparative study of the cognitive-enhancing activity of polymorphs was performed using the Statistics 7.1 software. Pairwise comparison using the Mann-Whitney U-test was used to identify differences between each polymorph with control and with scopolamine, as well as differences between polymorphs. The significance level was determined at p ≤ 0.05.
Full text: Click here
Publication 2023
Neutrophil Scopolamine
We designed an NMA using stochastic models and used a Bayesian approach to directly and indirectly compare the efficacy of drugs with different mechanisms of action for postoperative CRBD [17 (link), 18 (link)] (Fig. 2). ADDIS1.16.8 software was used for data analysis. We calculated direct and indirect odds ratios (OR) and 95% confidence intervals (95%CI) to analyze the effect on efficacy. The node-splitting model was used to test the consistency between closed-loop studies with both direct evidence and indirect evidence. If there was no significant difference (P > 0.05), the consistency model was used for network meta-analysis; if there was a significant difference (P < 0.05), the source of inconsistency was analyzed. The potential scale reduced factor (PSRF) reflects the convergence; if the PSRF is close to 1, it indicates that the convergence is better, the model analysis results are stable, and the conclusion is highly credible. The result is acceptable if PSRF < 1.02 (Table 2). The risk of bias was evaluated for each study according to the Cochrane Collaboration tool [19 (link)]. This tool assesses selection bias, performance bias, attrition bias, detection bias, reporting bias, and other sources of bias.

Networking of possible interventions based on our four results. Nodes are weighted according to the number of patients with the corresponding intervention. Edges are weighted according to the number of studies between two connected modes

The potential scale reduced factor of Bayesian model

ParameterPSRF
d.placebo.Chlorpheniramine1.00
d.placebo.Gabapentin1.00
d.placebo.Ketorolac1.01
d.placebo.Lidocaine1.00
d.placebo.Magnesium1.00
d.placebo.Nefopam1.00
d.placebo.Oxycodone1.00
d.placebo.Parecoxib1.01
d.placebo.Solifenacin1.00
d.placebo.Tolterodine1.00
d.placebo.bupivancaine1.00
d.placebo.dexmedetomidine1.00
d.placebo.Hyoscine N-butyl bromide1.00
d.placebo.ketamine1.00
d.placebo.pudendalnerveblock1.00
sd.d1.00
Full text: Click here
Publication 2023
Drug Kinetics Fibrinogen Patients Pharmaceutical Preparations Placebos Scopolamine Tooth Attrition

Top products related to «Scopolamine»

Sourced in United States, United Kingdom, Germany, Sao Tome and Principe, France, India, China
Scopolamine is a chemical compound used in various laboratory applications. It functions as a muscarinic antagonist, which means it blocks the effects of the neurotransmitter acetylcholine on muscarinic receptors. This property makes it useful in research and scientific experiments, but its specific applications and intended uses should not be extrapolated upon.
Sourced in United States, Sao Tome and Principe, Germany
Scopolamine hydrobromide is a chemical compound commonly used in laboratory settings. It is a crystalline solid that is soluble in water and organic solvents. Scopolamine hydrobromide is primarily used as a reference standard in analytical procedures and as a component in various research applications.
Sourced in United States, Germany, Sao Tome and Principe, United Kingdom, France
Pilocarpine is a pharmaceutical compound commonly used in laboratory settings. It functions as a cholinergic agonist, primarily activating muscarinic acetylcholine receptors. This product is utilized in various research applications, including the study of autonomic nervous system responses and the evaluation of ocular effects.
Sourced in United States, Germany, Italy, Japan, France
Donepezil is a laboratory equipment product manufactured by Merck Group. It is designed to assist in various research and analytical applications. The core function of Donepezil is to provide a reliable and consistent performance in the tasks it is intended for.
Sourced in United Kingdom
Scopolamine is a chemical compound used as a laboratory reagent. It is commonly employed in scientific research, particularly in the fields of pharmacology and neuroscience, to study the effects of muscarinic receptor antagonists. The core function of scopolamine is to act as a competitive antagonist at muscarinic acetylcholine receptors.
Sourced in United States
Scopolamine hydrochloride is a pharmaceutical compound used in various medical and research applications. It is a crystalline solid that is soluble in water and alcohol. Scopolamine hydrochloride is primarily used as a muscarinic antagonist, which means it blocks the action of acetylcholine on muscarinic receptors. This property makes it useful in a variety of clinical and experimental settings.
Sourced in United States, Macao, France
Methylscopolamine is a pharmaceutical compound used as a laboratory reagent. It functions as a muscarinic acetylcholine receptor antagonist.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, Germany, United Kingdom, Sao Tome and Principe, Macao
Pilocarpine hydrochloride is a chemical compound that is commonly used in laboratory settings. It is a crystalline solid with the molecular formula C11H16N2O2·HCl. Pilocarpine hydrochloride is a cholinergic agent, which means it acts on the parasympathetic nervous system to produce various physiological effects.
Sourced in United States, Germany, United Kingdom, China, France, Sao Tome and Principe, Italy, Australia, Spain, Canada, Belgium, New Zealand, Macao, Denmark, Switzerland, Chile
LiCl is a chemical compound consisting of lithium and chlorine. It is a crystalline solid that is highly soluble in water and other polar solvents. LiCl is commonly used as a laboratory reagent and in various industrial applications.

More about "Scopolamine"

Scopolamine, also known as hyoscine, is a tropane alkaloid compound derived from plants of the Solanaceae family, including Hyoscyamus, Atropa, and Datura species.
It is a potent muscarinic acetylcholine receptor antagonist with diverse pharmacological effects, including antisecretory, antispasmodic, and sedative properties.
Scopolamine has been used clinically as an antimotion sickness agent, a preoperative sedative, and a treatment for postoperative nausea and vomiting.
Researchers utilize scopolamine in a variety of experimental and clinical settings to study its effects on the central nervous system, cognition, and other physiological processes.
Scopolamine hydrobromide and scopolamine hydrochloride are common pharmaceutical salts of scopolamine, which may be used interchangeably.
Pilocarpine is another cholinergic agent that has been studied in relation to scopolamine, and Donepezil is an acetylcholinesterase inhibitor that can interact with scopolamine's effects.
DMSO, or dimethyl sulfoxide, has been used as a solvent for scopolamine in some research applications.
Methylscopolamine is a related compound that lacks the central nervous system effects of scopolamine.
Additionally, lithium chloride (LiCl) has been investigated for its potential to reverse scopolamine-induced cognitive impairments.
Researchers and clinicians continue to explore the diverse applications and mechanisms of scopolamine, utilizing advanced techniques and combining it with other pharmacological agents to better understand its impact on the body and mind.
The continued study of this complex and versatile compound promises to yield valuable insights and advancements in the fields of neuroscience, pharmacology, and medicine.